Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300214
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,985
Award facts
- Contract value 100% obligated
- $8,985.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
Bio-Rad Laboratories, Inc. was awarded a Blanket Purchase Agreement (BPA) call order valued at $8,985 by the Office of the Director, a civilian agency, for the procurement of drugs and biologicals. The award, issued on November 20, 2014, with an ultimate completion date of June 30, 2015, utilizes a firm fixed-price contract type with no small business set-aside designation. Performance of this order will occur in Bethesda, Maryland, at the agency's facilities. This call order represents a single transaction under Bio-Rad's broader BPA relationship with the National Institutes of Health (NIH), a $10 million agreement valid through December 31, 2025, which enables the procurement of biological materials, blood products, chemicals, laboratory supplies, and medical supplies supporting NIH research activities.
Bio-Rad Laboratories, Inc., headquartered in Hercules, California, is a global leader in life science research and clinical diagnostics, operating through its Life Science Group division. The company specializes in manufacturing advanced scientific instrumentation, laboratory equipment, reagents, and consumables, with particular expertise in polymerase chain reaction systems, thermal cyclers, droplet digital PCR instruments, gel imaging systems, and specialized diagnostic reagents. As a large, established federal contractor, Bio-Rad maintains an extensive portfolio of prime contracts and subcontract relationships across multiple federal agencies, including the Centers for Disease Control and Prevention, Food and Drug Administration, Department of Agriculture, Department of Veterans Affairs, and Department of Defense, demonstrating its critical role in supporting federal research and diagnostic capabilities.
Quick answers
Who was awarded contract HHSN26300214?
HHSN26300214 was awarded to Bio-Rad Laboratories, Inc. by Office of the Director (National Institutes of Health) on November 20, 2014.
How much is contract HHSN26300214 worth?
The government has obligated $8,985 on HHSN26300214.
Is contract HHSN26300214 an order under another contract?
Yes. HHSN26300214 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26300214 competed?
The extent of competition for HHSN26300214 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award